ZA201203239B - Methods and compositions for rapid treatment of otitis externa - Google Patents

Methods and compositions for rapid treatment of otitis externa

Info

Publication number
ZA201203239B
ZA201203239B ZA2012/03239A ZA201203239A ZA201203239B ZA 201203239 B ZA201203239 B ZA 201203239B ZA 2012/03239 A ZA2012/03239 A ZA 2012/03239A ZA 201203239 A ZA201203239 A ZA 201203239A ZA 201203239 B ZA201203239 B ZA 201203239B
Authority
ZA
South Africa
Prior art keywords
compositions
methods
otitis externa
rapid treatment
rapid
Prior art date
Application number
ZA2012/03239A
Other languages
English (en)
Inventor
William R Campbell
Neil E Paulsen
Roland H Johnson
Douglas I Hepler
Original Assignee
Bayer Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201203239(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Bv filed Critical Bayer Bv
Publication of ZA201203239B publication Critical patent/ZA201203239B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2012/03239A 2009-11-11 2012-05-04 Methods and compositions for rapid treatment of otitis externa ZA201203239B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11
PCT/US2010/056255 WO2011060083A1 (en) 2009-11-11 2010-11-10 Methods and compositions for rapid treatment of otitis externa

Publications (1)

Publication Number Publication Date
ZA201203239B true ZA201203239B (en) 2013-07-31

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/03239A ZA201203239B (en) 2009-11-11 2012-05-04 Methods and compositions for rapid treatment of otitis externa

Country Status (29)

Country Link
US (1) US8927006B2 (enExample)
EP (1) EP2498792B1 (enExample)
JP (2) JP2013510861A (enExample)
KR (2) KR20120116398A (enExample)
CN (1) CN102612372B (enExample)
AU (1) AU2010319538B2 (enExample)
BR (1) BR112012011017A2 (enExample)
CA (1) CA2780160C (enExample)
CL (1) CL2012001227A1 (enExample)
CO (1) CO6540004A2 (enExample)
DK (1) DK2498792T3 (enExample)
EC (1) ECSP12011967A (enExample)
ES (1) ES2645200T3 (enExample)
HR (1) HRP20171520T1 (enExample)
HU (1) HUE034617T2 (enExample)
IL (1) IL219483A (enExample)
LT (1) LT2498792T (enExample)
MX (1) MX2012005521A (enExample)
MY (1) MY162687A (enExample)
NO (1) NO2498792T3 (enExample)
NZ (1) NZ599559A (enExample)
PH (1) PH12012500913A1 (enExample)
PL (1) PL2498792T3 (enExample)
PT (1) PT2498792T (enExample)
RU (1) RU2680137C2 (enExample)
SI (1) SI2498792T1 (enExample)
UA (1) UA111147C2 (enExample)
WO (1) WO2011060083A1 (enExample)
ZA (1) ZA201203239B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
US11779538B2 (en) 2017-11-14 2023-10-10 Profem Gmbh Emulsions for treating mucous membrane infections
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
BR112022005354A2 (pt) * 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
EP4041153A4 (en) * 2019-10-11 2023-10-25 Piedmont Animal Health Inc. OTIC FORMULATIONS, METHODS AND DEVICES
CA3213099A1 (en) 2021-03-24 2022-09-29 Robert A. Love Peptides and methods for reducing skin pigmentation
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691249B2 (en) 1994-02-04 1998-05-14 Lipocore Holding Ab Bilayer preparations
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
IT1295369B1 (it) * 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
US20070054844A1 (en) * 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
US20070078116A1 (en) 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US20050159369A1 (en) * 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20080124385A1 (en) 2004-09-03 2008-05-29 Piedmont Pharmaceuticals,Llc. Methods for Transmembrane Treatment and Prevention of Otitis Media
TW200719884A (en) 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
US20090082337A1 (en) 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Also Published As

Publication number Publication date
NZ599559A (en) 2014-08-29
SI2498792T1 (sl) 2017-11-30
US20110281809A1 (en) 2011-11-17
IL219483A (en) 2017-12-31
RU2680137C2 (ru) 2019-02-18
RU2012124067A (ru) 2013-12-20
LT2498792T (lt) 2017-10-25
CA2780160A1 (en) 2011-05-19
UA111147C2 (uk) 2016-04-11
ECSP12011967A (es) 2012-08-31
PH12012500913A1 (en) 2012-11-26
NO2498792T3 (enExample) 2017-12-30
HUE034617T2 (en) 2018-02-28
AU2010319538A1 (en) 2012-05-17
JP6138891B2 (ja) 2017-05-31
MY162687A (en) 2017-07-14
PL2498792T3 (pl) 2018-01-31
DK2498792T3 (da) 2017-11-06
JP2013510861A (ja) 2013-03-28
WO2011060083A1 (en) 2011-05-19
HRP20171520T1 (hr) 2017-11-17
KR20170100680A (ko) 2017-09-04
PT2498792T (pt) 2017-10-18
ES2645200T3 (es) 2017-12-04
EP2498792A4 (en) 2013-06-12
CO6540004A2 (es) 2012-10-16
KR20120116398A (ko) 2012-10-22
KR101901083B1 (ko) 2018-09-20
EP2498792A1 (en) 2012-09-19
BR112012011017A2 (pt) 2015-09-15
EP2498792B1 (en) 2017-08-02
JP2016102112A (ja) 2016-06-02
CN102612372B (zh) 2016-01-20
MX2012005521A (es) 2012-06-19
CL2012001227A1 (es) 2012-08-24
IL219483A0 (en) 2012-06-28
AU2010319538B2 (en) 2015-04-09
US8927006B2 (en) 2015-01-06
CA2780160C (en) 2018-03-06
CN102612372A (zh) 2012-07-25

Similar Documents

Publication Publication Date Title
IL219483A0 (en) Methods and compositions for rapid treatment of otitis externa
EP2771030A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROTEINOPATHIES
EP2293800A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EARLIER DISEASES
IL216926A0 (en) Diagnostic methods and compositions for treatment of cancer
SG10201402491YA (en) Methods and compositions for diagnosis and treatment of cancer
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2482814A4 (en) METHOD AND COMPOSITIONS FOR TREATING OKULAR FIBROSIS
IL214455A0 (en) Methods and compositions for treatment of neovascularization
IL236516A0 (en) Methods and preparations for the diagnosis and treatment of cancer
IL215592A0 (en) Compositions and methods for the treatment of inflammation
SI2424372T1 (sl) Antimikrobni sestavki in s tem povezane metode uporabe
IL216993A0 (en) Compositions and methods for treatment of multiple sclerosis
GB0902040D0 (en) Composition for treatment of skin
IL214349A0 (en) Compositions and methods for the treatment of cancer
ZA201301936B (en) Methods and compositions for treatment of diabetes and dyslipidemia
DK2473482T3 (en) Methods of treating orthomyxoviral infections
IL215093A0 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
PL2328402T3 (pl) Sposoby i kompozycje do wydłużenia okresu przechowywania owoców
EP2515652A4 (en) COMPOSITIONS AND METHODS FOR TREATING VITILIGO
GB201010638D0 (en) Composition for treatment of skin
HK1166271A (en) Compositions and methods for prophylaxis and treatment of addictions
GB201011469D0 (en) Method of and composition for combating undesired microorganisms
AU2009901447A0 (en) Composition and method of treatment
AU2009900091A0 (en) Methods of treatment and prophylaxis
IL209658A0 (en) Compositions and methods for treatment of ear disorders